CFO
EHC icon

Callan Family Office’s Encompass Health EHC Stock Holding History

Callan Family Office’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$416K Sell
4,114
-549
-12% -$56.9K 0.01% 878
2026
Q1 		$451K Sell
4,663
-798
-15% -$81.8K 0.01% 801
2025
Q4 		$580K Buy
+5,461
New +$633K 0.01% 735
2025
Q3 		– Sell
-2,101
Closed -$258K – 884
2025
Q2 		$258K Buy
+2,101
New +$240K 0.01% 813

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Callan Family Office's EHC Position: Q2 2026 in Review

Callan Family Office reduced its Encompass Health (EHC) stake by 12% in Q2 2026, selling an estimated $56.9K and leaving 4,114 shares worth $416K. The position accounts for 0.01% of the portfolio, ranked #878.

Callan Family Office first reported a position in EHC in Q2 2025 and has held it in 4 quarters since. The position peaked at $580K in Q4 2025. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Callan Family Office held 4,114 shares of Encompass Health worth $416K as of Q2 2026.
  • Callan Family Office sold 549 Encompass Health shares in Q2 2026, an estimated $56.9K.
  • Encompass Health made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #878 holding.
  • Callan Family Office first reported a position in Encompass Health in Q2 2025 and has held it in 4 quarters since.
  • Callan Family Office's Encompass Health position peaked at $580K in Q4 2025.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.